ELIX news

Latest 1 stories · newest Jun 24, 2026

ELIX

Elicio presents path forward for ELI-002 7P in PDAC

Elicio Therapeutics is disclosing the clinical roadmap for ELI-002 7P in metastatic pancreatic ductal adenocarcinoma. The company outlines the planned Phase 1 study evaluating combination therapy.

Other Jun 24, 2026 sentiment +0.40 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ELIX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ELIX/newsSTART FREE